brca3 | 59563
Genetics Carriership of a familial variant
Keywords:
ATM
BARD1
BRCA1
BRCA2
BRIP1
CDH1
CDKN2A
CHEK2
EPCAM
HBOC
HNPCC
HOXB13
Hereditary cancer
Lynch syndrome
MLH1
MSH2
MSH6
PALB2
PMS2
PTEN
RAD51C
RAD51D
STK11
TP53
breast and ovarian cancer
carriership of a pathogenic familial variant
endometrial cancer
pancreatic cancer
prostate cancer
Status
Material |
|
||
---|---|---|---|
Hint |
Search for mutations or gene dosage changes known in the family, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53. | Preliminary findings of a known mutation or gene dosage change in the family are required for the analysis to be carried out. | Declaration of consent for genetic examination in accordance with GUMG required (see OF Human genetics or www.viollier.ch/en/SGMG_consent) | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. |
||
Min. volume | 4 mL | ||
Stability |
Stability
1 week / 2-8°C
|
||
Duration | 3 weeks | ||
Frequency | 1 x per month | ||
Method | Next Generation Sequencing |
Price/Rate
Price |
Price
CHF 338.40
|
---|---|
Rate |
Rate
338.40 TP
|